March 27, 2018 / 1:26 AM / in 9 months

BRIEF-‍Aslan Pharmaceuticals Files For Proposed IPO In U.S.​

March 26 (Reuters) - Aslan Pharmaceuticals Ltd:

* ‍ASLAN PHARMACEUTICALS FILES FOR PROPOSED INITIAL PUBLIC OFFERING IN U.S.​

* ‍ASLAN HAS APPLIED TO LIST ITS ADSS ON NASDAQ GLOBAL MARKET UNDER TRADING SYMBOL "ASLN"​

* ‍LEERINK PARTNERS AND PIPER JAFFRAY & CO. ARE ACTING AS JOINT BOOK-RUNNING MANAGERS FOR THIS OFFERING​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below